Skip to main content

Advertisement

Log in

Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the role of osteopontin (OPN) in cyclosporine (CsA) nephrotoxicity of the human kidney. Renal biopsy samples obtained before and after 1–2 years of CsA treatment were evaluated in 18 children (2.2–13.0 years, 14 males, 4 females) diagnosed with minimal change nephrotic syndrome. The changes in tubular OPN expression between pre- and post-treatment samples were correlated with interstitial macrophage infiltration, transforming growth factor-β (TGF-β) expression, interstitial fibrosis, and microvascular density. OPN, TGF-β, CD68, and CD34 positivity were quantitatively assessed by immunohistochemical staining. Light microscopy showed that interstitial fibrosis developed in two-thirds of patients after CsA treatment. However, CD68-positive macrophages infiltrated minimally in fibrotic areas and were found in only one-third of patients. OPN expression was significantly increased in the glomerular mesangium (P=0.001) and tubules (P=0.025) after CsA treatment, whereas the number of CD34-positive peritubular capillaries decreased (P=0.022). An inverse relationship was observed between tubular OPN expression and microvascular density (r=−0.644). However, tubular OPN expression was not related to proteinuria, interstitial fibrosis, or interstitial or tubular TGF-β expression. This study indicates that increased OPN expression may be related to microvascular injury in human CsA nephrotoxicity. It also shows that OPN expression may be used as an early but non-specific marker of CsA toxicity before the manifestation of interstitial fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Habib R, Niaudet P (1994) Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis. Clin Nephrol 42:141–146

    CAS  PubMed  Google Scholar 

  2. Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K (1998) Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine. Am J Kidney Dis 31:932–939

    CAS  PubMed  Google Scholar 

  3. Kuncio GS, Neilson EG, Haverty T (1991) Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550–556

    CAS  PubMed  Google Scholar 

  4. Wolf G, Thaiss F, Stahl RA (1995) Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 60:237–241

    CAS  PubMed  Google Scholar 

  5. Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ, Pollock CA (1999) Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor. J Pharmacol Exp Ther 289:535–542

    CAS  PubMed  Google Scholar 

  6. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F (2001) Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60:1645–1657

    Article  CAS  PubMed  Google Scholar 

  7. Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, Andoh T, Bennett WM, Couser WG (1995) Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48:439–448

    CAS  PubMed  Google Scholar 

  8. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, Johnson RJ (1995) Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186–1196

    CAS  PubMed  Google Scholar 

  9. Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ (1998) Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897–908

    Article  CAS  PubMed  Google Scholar 

  10. Hudkins KL, Le QC, Segerer S, Johnson RJ, Davis CL, Giachelli CM, Alpers CE (2001) Osteopontin expression in human cyclosporine toxicity. Kidney Int 60:635–640

    Article  CAS  PubMed  Google Scholar 

  11. Faraggiana T, Malchiodi F, Prado A, Churg J (1982) Lectin-peroxidase conjugate reactivity in normal human kidney. J Histochem Cytochem 30:451–458

    CAS  PubMed  Google Scholar 

  12. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG (1994) Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum Pathol 25:22–28

    CAS  PubMed  Google Scholar 

  13. Vieira JM Jr, Noronha IL, Malheiros DM, Burdmann EA (1999) Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow. Transplantation 68:1746–1753

    Article  CAS  PubMed  Google Scholar 

  14. Basile DP, Donohoe D, Roethe K, Osborn JL (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281:F887–F899

    CAS  PubMed  Google Scholar 

  15. Kang DH, Kim YK, Andoh TF, Gordon KL, Suga S, Mazzali M, Jefferson JA, Hughes J, Bennett W, Schreiner GF, Johnson RJ (2001) Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol 280:F727–F736

    CAS  PubMed  Google Scholar 

  16. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ (1998) Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 9:231–242

    CAS  PubMed  Google Scholar 

  17. Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD (2000) Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 31:1491–1497

    Article  CAS  PubMed  Google Scholar 

  18. Persy VP, Verstrepen WA, Ysebaert DK, De Greef KE, De Broe ME (1999) Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. Kidney Int 56:601–611

    Article  CAS  PubMed  Google Scholar 

  19. Sodhi CP, Batlle D, Sahai A (2000) Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK. Kidney Int 58:691–700

    Article  CAS  PubMed  Google Scholar 

  20. Sahai A, Mei C, Schrier RW, Tannen RL (1999) Mechanisms of chronic hypoxia-induced renal cell growth. Kidney Int 56:1277–1281

    Article  CAS  PubMed  Google Scholar 

  21. Sodhi CP, Phadke SA, Batlle D, Sahai A (2001) Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin. Am J Physiol Renal Physiol 280:F667–F674

    CAS  PubMed  Google Scholar 

  22. Jeong HJ, Kim JH, Kim PK, Choi IJ (2001) Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome. Clin Nephrol 55:289–296

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by a grant from the Korean Society of Nephrology (Chong Kun Dang 2003) to H.J. Jeong.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyeon Joo Jeong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lim, B.J., Kim, P.K., Hong, S.W. et al. Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity. Pediatr Nephrol 19, 288–294 (2004). https://doi.org/10.1007/s00467-003-1386-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1386-8

Keywords

Navigation